AnalysisNews

BSEM today

$0.63-$0.08 (-11.15%)close Nov 20, 2026

Trend

DailyUptrend (starting)

4 hourStrong Bearish

1 hourStrong Bearish

15 minStrong Bearish

5 minStrong Bearish

Daily trend turns down below $3.42

Key levels

Resistance$1.60

Resistance$1.01

Latest news & SEC filings

GuidanceBioStem Technologies reports Q3 2026 results, boosts full-year revenue outlook

EarningsBioStem Technologies posts wider quarterly loss, revenue tops forecast

All BSEM news →

Nasdaq · Healthcare

BioStem Technologies, Inc. (BSEM)

$0.63-0.08 (-11.15%)
Risk: LOW
1D5D1M1Y5YMaxSign up for all timeframes
0.991.351.722.080.63Oct 20Oct 28Nov 5Nov 13
High0.71
Low0.60
Open0.70
Volume170K
Avg Vol226K
VWAP0.65
30d High2.44
30d Low0.63
30d Chg-74.24%

What Is the Price Target for BSEM?

SEPT Low Target

$0.00

SEPT Mid Target

$0.00

SEPT High Target

$0.00

Analyst Consensus

$0.00

Current: $0.64Upside: +0.0%Confidence: 20%Method: No Coverage

Is BSEM a Buy or Sell Right Now?

0
Investability Score
12-18 months
News summary · last 30 days
Critical news
Nov 11HIGHPrice move report
Nov 11HIGHPrice move report

Test your own strategy on BSEM

Describe your strategy in plain words, then scan, alert, backtest and paper trade it on BSEM with SEPT’s own market data.

Start Free Trial →

Is BSEM Overvalued or Undervalued?

Valuation Verdict

N/A

Methods Used

N/A

Fair Value

$N/A

0

Moat Score

NONE

0/9

Piotroski Score

N/A

Altman Z-Score

What Is Smart Money Doing with BSEM?

Insider Signal

NEUTRAL

0 buys / 0 sells (90d)

Congress Signal

NEUTRAL

0 buys / 0 sells (90d)

Institutional

N/A

Short Squeeze Risk

LOW

Signal: NEUTRAL

Recent Insider Activity

NameTitleTypeSharesValueDate
Matuszewski Jasondirector officer 10% ownerSale14,300$14KNov 17, 2026
POE BRANDONofficerBuy2,699-Nov 11, 2026
FORTUNATO MICHAEL AofficerBuy970-Nov 9, 2026
HASSETT BARRYofficerBuy253-Nov 1, 2026
Matuszewski Jasondirector officer 10% ownerBuy250,000$500KOct 7, 2026
SMITH-VAN VURST ANDREWdirector officer 10% ownerBuy250,000$500KOct 7, 2026
Matuszewski Jasondirector officer 10% ownerBuy16,650-Sep 17, 2026
Matuszewski Jasondirector officer 10% ownerBuy8,469-Sep 15, 2026
HASSETT BARRYofficerBuy500-Sep 9, 2026

Track Smart Money Across 4,000+ Stocks

Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.

See Smart Money Data →

BSEM Growth Story

Revenue YoY

N/A%

3yr Revenue CAGR

N/A%

EPS Growth YoY

N/A

FCF Growth YoY

N/A%

Revenue Trend

UNKNOWN

Dark Pool Trades for BSEM

PREVIEW

Recent off-exchange (dark pool) prints for BSEM: size, dollar value and side. One of the data views on SEPT, alongside its own pressure bars, swings, volume spike levels and key levels.

TimePriceSizeValueSide
17:58:50$0.605,000$$3KSELL
17:58:02$0.604,600$$3KSELL
17:56:33$0.604,500$$3KSELL
17:55:58$0.601,883$$1KSELL
17:55:58$0.6016,945$$10KSELL

5 dark pool trades shown · $$20K preview volume

Real-time institutional flow, block trades, and net positioning

See all dark pool activity

What Traders Are Saying About BSEM

1 posts

SEPT Investing hosts an active trader community sharing real-time analysis, trade setups, and market discussion for BSEM. Join verified traders discussing price action, dark pool alerts, options flow, and AI-powered market intelligence.

N
Nicole AdamsVERIFIED63d ago

Smart Money Moves $CLBT — Richardson Troy | Sale $CLBT — Van Buren Brandon | Sale $PLAY — Lipman Nathaniel | Sale $81K $KLXE — Whates John T | Sale $156K $BSEM — Matuszewski Jason | Sale

61 views

Join traders discussing BSEM in real-time

Trade ideas, setups, dark pool alerts, and AI-powered analysis

Join the discussion

Full AI Research Report

SEPT's Trading AI has generated a free, downloadable PDF research report for BioStem Technologies, Inc. (BSEM) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.

Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (2 articles analyzed), and SEC filing intelligence...

Your strategy, tested before real money.

Describe your strategy in plain words. SEPT scans, alerts, backtests and paper trades it on its own market data. SEPT provides tools only and does not tell you what to buy or sell.

Try SEPT Free for 7 Days →

BSEM — frequently asked questions

What is BSEM stock price today?

BioStem Technologies, Inc. (BSEM) is at $0.63, down 11.15% (-$0.08) at the Nov 20, 2026 close.

Why is BSEM stock moving today?

Latest BSEM news — Nov 13, 2026: BioStem Technologies reports Q3 2026 results, boosts full-year revenue outlook · Nov 12, 2026: BioStem Technologies posts wider quarterly loss, revenue tops forecast

Did BSEM beat earnings?

BSEM last reported on Aug 12, 2026: EPS -$0.52 vs -$0.50 expected — a miss of 4.0%.

How much debt does BSEM have?

BioStem Technologies, Inc. reported $0M of debt and $7M of cash (Jun 30, 2026).

What are BSEM support and resistance levels?

Resistance: $1.01, $1.60, $3.42.

What are insiders doing with BSEM?

Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.

What is the latest news on BSEM?

Nov 13, 2026: BioStem Technologies reports Q3 2026 results, boosts full-year revenue outlook · Nov 12, 2026: BioStem Technologies posts wider quarterly loss, revenue tops forecast